Gujarat Kidney and Super Speciality
Gujarat Kidney and Super Speciality Share Price Chart
Gujarat Kidney and Super Speciality last traded at ₹182.76 (2026-10-13). Over the past month the stock moved +4.8%, three months the stock moved +29.7%. Its closing range over 52 weeks is ₹99.36 – ₹195.10, with the latest close 6.3% below the high.
Closing prices up to 2026-10-13.
About Gujarat Kidney and Super Speciality
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
Business Profile[1] Gujarat Kidney and Super Speciality Limited is a regional healthcare operator in central Gujarat, running a chain of mid-sized multi-speciality hospitals focused on secondary and tertiary care.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Gujarat Kidney and Super Speciality reported sales of ₹34.29 crore (+124.7%) and net profit of ₹5.32 crore (-1.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 34.29 | 8.37 | 24.41 | 5.32 | 0.66 |
| Mar 2026 | 30.58 | 6.30 | 20.60 | 4.82 | 0.64 |
| Dec 2025 | 23.25 | 6.90 | 29.68 | 3.70 | 0.37 |
| Sep 2025 | 12.93 | 5.12 | 39.60 | 2.88 | 0.47 |
| Jun 2025 | 15.26 | 8.62 | 56.49 | 5.40 | 0.85 |
| Mar 2025 | 9.78 | 2.61 | 26.69 | 1.34 | 0.23 |
| Dec 2024 | 11.79 | 4.60 | 39.02 | 2.53 | 15.53 |
| Sep 2024 | 9.41 | 4.86 | 51.65 | 2.96 | 18.39 |
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales growth | +37.4% | +97.2% | +212.7% | +124.7% |
| Operating profit growth | +5.3% | +50.0% | +141.4% | -2.9% |
| Net profit growth | -2.7% | +46.2% | +259.7% | -1.5% |
| EPS growth | -97.4% | -97.6% | +178.3% | -22.4% |
| OPM % | 39.6% | 29.7% | 20.6% | 24.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Gujarat Kidney and Super Speciality reported sales of ₹82.00 crore (+103.8%) and net profit of ₹17.00 crore (+78.9%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 82.00 | 27.00 | 33.00 | 17.00 | 1.97 |
| Mar 2025 | 40.24 | 16.56 | 41.15 | 9.50 | 1.66 |
| Mar 2024 | 4.77 | 1.96 | 41.09 | 1.71 | 85.50 |
| Mar 2023 | 0.00 | -0.01 | – | -0.01 | -0.50 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | – | +743.6% | +103.8% |
| Operating profit growth | – | +744.9% | +63.0% |
| Net profit growth | – | +455.6% | +78.9% |
| EPS growth | – | -98.1% | +18.7% |
| OPM % | 41.1% | 41.2% | 33.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Gujarat Kidney and Super Speciality.
Get Free AI Stock Analysis FREE →Latest News
-
Gujarat Kidney and Super Speciality gets nod to incorporate wholly owned subsidiary
Frequently Asked Questions
What is Gujarat Kidney and Super Speciality's current stock price?
Gujarat Kidney and Super Speciality shares were last quoted at ₹182.76 (-0.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Gujarat Kidney and Super Speciality?
Gujarat Kidney and Super Speciality has a price-to-earnings (P/E) ratio of 88.61 and a price-to-book (P/B) ratio of 5.45. The industry P/E is 101.02.
What is the 52-week high and low of Gujarat Kidney and Super Speciality?
The 52-week high of Gujarat Kidney and Super Speciality is ₹186.85 and the 52-week low is ₹98.25.
What is the market cap of Gujarat Kidney and Super Speciality?
The market capitalisation of Gujarat Kidney and Super Speciality is about ₹1,404.20 crore.
How did Gujarat Kidney and Super Speciality perform in its latest quarterly results?
In the latest quarter (Jun 2026), Gujarat Kidney and Super Speciality reported sales of ₹34.29 crore (+124.7%) and net profit of ₹5.32 crore (-1.5%), compared with the same quarter last year.
Is Gujarat Kidney and Super Speciality a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Gujarat Kidney and Super Speciality has a 3-year ROE of 16.00%, 3-year profit growth of 1,058.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Gujarat Kidney and Super Speciality?
Promoters hold about 71.45% of Gujarat Kidney and Super Speciality.
Which sector does Gujarat Kidney and Super Speciality belong to?
Gujarat Kidney and Super Speciality belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z